Last reviewed · How we verify

NCT04600037

Pregabalin Treatment for Trigger Points

Completed NA Last updated 23 October 2020
What this trial tests

NA trial testing Pregabalin 150mg in Myofascial Pain Syndrome in 40 participants. Completed in 26 January 2015.

Timeline
26 April 2014
Primary endpoint
26 July 2014
26 January 2015

Quick facts

Lead sponsorFatih Sultan Mehmet Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment40
Start date26 April 2014
Primary completion26 July 2014
Estimated completion26 January 2015
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Fatih Sultan Mehmet Training and Research Hospital

Who can join

Adults 18 to 65, female only, with Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of pregabalin treatment for trigger points in patients with comorbid myofascial pain syndrome and fibromyalgia syndrome: a randomized controlled trial.
    Karamanlioglu DS, Geler Kulcu D, Ozturk G, Akpinar P, et al · · 2021 · cited 5× · PMID 34544324 · DOI 10.1080/08990220.2021.1977265

Verify or expand the search:

Other trials of Pregabalin 150mg

Trials testing the same drug.

Other recruiting trials for Myofascial Pain Syndrome

Currently open trials in the same condition.

Other Fatih Sultan Mehmet Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04600037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing